Oct 12, 2026 07:56AM
Oct 12, 2026 07:55AM
Oct 8, 2026 07:34AM
Oct 8, 2026 07:32AM
Oct 7, 2026 08:41AM
Oct 7, 2026 08:40AM
Sep 23, 2026 07:59AM Clearmind files 3 U.S. patent applications on LSD, ketamine, ibogaine
Sep 23, 2026 07:57AM
Sep 17, 2026 07:44AM
Sep 17, 2026 07:42AM
Sep 11, 2026 08:01AM
Sep 11, 2026 08:00AM
Sep 8, 2026 07:43AM
Sep 8, 2026 07:42AM Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
Sep 4, 2026 07:32AM
Sep 4, 2026 07:32AM
Sep 1, 2026 07:37AM
Sep 1, 2026 07:37AM
Aug 24, 2026 08:05AM
Aug 24, 2026 08:03AM
Aug 13, 2026 07:36AM Clearmind gets DSMB approval to test CMND-100 in AUD patients
Aug 13, 2026 07:36AM
Aug 6, 2026 08:00AM
Aug 6, 2026 08:00AM
Aug 3, 2026 08:02AM
Aug 3, 2026 08:02AM
Jul 30, 2026 08:30AM
Jul 30, 2026 08:30AM Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial
Jul 28, 2026 07:47AM
Jul 28, 2026 07:47AM
Jul 20, 2026 07:55AM
Jul 20, 2026 07:55AM
Jul 17, 2026 07:32AM
Jul 17, 2026 07:32AM
Jul 16, 2026 09:30AM Clearmind reports improved nasal retention for its MEAI drug formulation
Jul 16, 2026 09:30AM
Jul 13, 2026 08:17AM
Jul 13, 2026 08:17AM
Jul 10, 2026 08:32AM
Jul 10, 2026 08:32AM
Jul 7, 2026 07:43AM
Jul 7, 2026 07:42AM Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
Jun 29, 2026 07:55AM
Jun 29, 2026 07:55AM
Jun 22, 2026 08:07AM
Jun 22, 2026 08:07AM
Jun 18, 2026 07:55AM
Jun 18, 2026 07:55AM
Jun 16, 2026 07:32AM Clearmind Medicine completes Part A dosing in Phase I/II alcohol disorder trial
Jun 16, 2026 07:32AM

1,199,668 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All